• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Danske Invest-Bioteknologi Fund

+ Add to Watchlist

DANIBIO:DC

252.9000 DKK 5.5000 2.22%

As of 11:20:00 ET on 11/21/2014.

Snapshot for Danske Invest-Bioteknologi Fund (DANIBIO)

Open: 250.0000 High - Low: 253.4000 - 249.4000 Primary Exchange: Copenhagen
Volume: 13,564 52-Week Range: 160.1000 - 256.4000 Beta vs BTK: 0.9633

ETF Chart for DANIBIO

No chart data available.
  • DANIBIO:DC 252.9000
  • 1D
  • 1M
  • 1Y
247.4000
Interactive DANIBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DANIBIO

Danske Invest Bioteknologi Fund is an open-end fund registered in Denmark. The Fund's objective is capital appreciation, and to outperform NASDAQ's biotech-index(NBI). The Fund invests worldwide in equity of biotechnology companies, and companies closely related to the biotechnology sector.

Inception Date: 2000-05-26 Telephone: 45-3333-7171
Managers: -
Web Site: www.danskeinvest.dk

Fundamentals for DANIBIO

NAV (on 2014-11-21) 248.9100
Assets (M) (on 2014-10-31) 790.7908
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium 1.60
Average 52-Week % Premium 0.8560
Fund Leveraged N

Dividends for DANIBIO

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-04-25) 12.8000
Dividend Yield (ttm) 5.06%

Performance for DANIBIO

1-Month +9.81% 1-Year +62.77%
3-Month +22.29% 3-Year +51.30%
Year To Date +59.34% 5-Year +33.97%
Expense Ratio 1.50

Top Fund Holdings for DANIBIO

Filing Date: 08/31/2014
Name Position Value % of Total
InterMune Inc 127,510 52,970,951 7.691%
Pharmacyclics Inc 56,122 39,483,926 5.733%
United Therapeutics Corp 57,698 38,451,949 5.583%
Exact Sciences Corp 325,401 38,373,081 5.572%
Nektar Therapeutics 474,154 38,242,006 5.553%
Gilead Sciences Inc 59,985 36,491,791 5.299%
BioMarin Pharmaceutical Inc 90,550 36,474,735 5.296%
Celgene Corp 62,351 33,508,900 4.865%
Biogen Idec Inc 17,248 33,464,569 4.859%
Amgen Inc 42,431 33,449,178 4.857%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil